Mi SciELO
Servicios Personalizados
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en
SciELO
Compartir
Revista Cubana de Medicina General Integral
versión On-line ISSN 1561-3038
Resumen
HECHAVARRIA BARZAGA, Kenia María et al. COVID-19 in Medical Students from Universidad de Ciencias Médicas de Holguín. Rev Cubana Med Gen Integr [online]. 2023, vol.39, n.4 Epub 22-Abr-2024. ISSN 1561-3038.
Introduction:
The high incidence of sick people caused by COVID-19 has affected around 188 countries, of which Cuba is not exempt, with cases increasing to alarming figures.
Objective:
To characterize, clinically and epidemiologically, SARS-CoV-2-positive medical sciences students, initially asymptomatic, from a student residence.
Methods:
An observational, descriptive, case series study was carried out. The universe consisted of 26 COVID-19-positive patients who met the selection criteria, all of whom were studied. The following variables were used: age, sex, race, individual disease history, hematologic variables, present symptoms, polymerase chain reaction result, received treatment, adverse reactions to treatment. Descriptive statistics were used. The Kolmogorov-Smirnov test and Pearson's chi-squared test were applied, with 95 % reliability.
Results:
The male sex (76.9 %), black skin color (100 %) and a mean age of 25.2 years characterized the study. Infectious history (76.32 %, p = 0.006) was the most frequent comorbidity. Decreases in the frequency of symptoms present in patients were associated over time with CRP 1 (p = 0.047), CRP 2 (p = 0.000) and CRP 3 (p = 0.013). Being treated with these treatment schemes had a statistically significant relationship with the occurrence of adverse reactions (chi square = 4.33; p = 0.03) and post-COVID-19 electrocardiographic alterations.
Conclusions:
The presence of infectious history, decrease of symptoms according to the evolution of CRP results, and the risk of adverse reactions to the applied treatment schemes characterized the studied patients.
Palabras clave : coronavirus infections; COVID-19; SARS-CoV-2; therapeutics; adverse reaction; electrocardiogram.












